PHGE — Biomx Cashflow Statement
0.000.00%
Last trade - 00:00- $16.01m
- $12.29m
Annual cashflow statement for Biomx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 June 30th | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.347 | -30.1 | -36.2 | -28.3 | -26.2 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -0.881 | 3.01 | 2.98 | 1.13 | 1.54 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.33 | 0.453 | 3.1 | -4.43 | 2.48 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.205 | -24.4 | -27.6 | -29.1 | -21.3 |
| Capital Expenditures | — | -1.01 | -3.68 | -0.112 | -0.05 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -70 | -9.85 | 19.9 | -2 | 2 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -70 | -10.9 | 16.2 | -2.11 | 1.95 |
| Financing Cash Flow Items | 0.241 | -0.075 | — | — | -0.333 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 70.9 | 0.134 | 37.3 | 0.292 | 2.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.696 | -35.2 | 25.9 | -30.8 | -16.4 |